integrative dermatology symposium
2022 Integrative Dermatology Symposium

ACCREDITATION

September 30, 2022 - October 2, 2022

Certificates for IDS 2022 are available at LearnSkin. Please complete the evaluation form to generate your certificate. If you are not currently a member, a basic LearnSkin membership has been created for you. Look for the email titled “Thank you for joining us at IDS2022!” from events@learnskin.com.

Our team can be reached at events@learnskin.com if you have any questions.

________________________________________________________

The 2022 Integrative Dermatology Symposium is approved for 15.5 credits of continuing medical education (CME) by Your CE Source. 

 
CREDIT STATEMENT 
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Your CE Source and Learn Health Inc. Your CE Source is accredited by the ACCME to provide continuing medical education for physicians. 
 
CREDIT DESIGNATION 
Your CE Source designates this live activity for a maximum of 15.5 AMA PRA Category 1 Credits™. Physicians should claim the credit commensurate with the extent of their participation in the activity. 
 
FOR NURSES 
Your CE Source is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 16031 for 16 contact hours. Nurses should claim the credit commensurate with the extent of their participation in the activity. 
 
FOR NATUROPATHIC DOCTORS 
The Integrative Dermatology Symposium is approved for 13.5 General and 2 Pharmacology (Total 15.5 CE) credit(s) of continuing education credits by the American Association of Naturopathic Physicians.
 
FOR ACUPUNCTURISTS AND ORIENTAL MEDICINE PRACTITIONERS 
The Integrative Dermatology Symposium is approved by the National Certification Commission for Acupuncture and Oriental Medicine and is applying for 16 PDA Points. NCCAOM® PDA Points Provider #9093.
 
CALIFORNIA ACUPUNCTURE BOARD 
IDS 2022 (LearnHealth Inc.) is approved by the California Acupuncture Board, Provider Number 1658, for 15 hours of Category 1 continuing education.
 
FOR AYURVEDA PRACTITIONERS 
The Integrative Dermatology Symposium has been approved for 0.5 TIA and 15 TIW PACE Credits by the National Ayurvedic Medical Association (NAMA). A certificate of completion for this course will be given to all that participate in the 2022 Integrative Dermatology Symposium after completing an evaluation form.
 
FOR ADVANCED PERSONALIZED NUTRITION PRACTITIONERS
The Board for Certification of Nutrition Specialists℠ , the certifying arm of the American Nutrition Association® (ANA®), designates this activity for a maximum of 3.25 continuing education credits for the Certified Nutrition Specialist®.
 
GOAL & PURPOSE
The annual Integrative Dermatology Symposium is designed to appeal to practitioners across disciplines. It will address emerging trends, and practical approaches to dermatology as practitioners assess and manage skin conditions and care. It is estimated that nearly one-third of the population is afflicted with a skin disorder. There is a great need for best practice sharing and cross-collaboration to support practitioners in the field and improve patient outcomes.
TARGET AUDIENCE
This live symposium is designed to meet the educational needs of:
DISCLOSURE OF CONFLICTS OF INTEREST
Your CE Source ensures balance, independence, objectivity, and scientific rigor in all our educational programs. In accordance with this policy, Your CE Source identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Your CE Source to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. Your CE Source is committed to providing its learners with high-quality activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.
 
The faculty reported the following financial relationships with commercial interests whose products or services may be mentioned in this CE activity:
Name of Faculty
Reported Financial Relationship
Akilesh Palanisamy

MD

No financial relationships to disclose.

Apple Bodemer

MD

No financial relationships to disclose.

Brindley Brooks

No financial relationships to disclose.

Cassandra Quave, PhD
Cassandra Quave

PhD

Grants/​Research Support: National Institutes of Health
Consulting Fees: CEO consulting small business – CLQ Botanicals LLC
Speakers Bureau: Represented by BrightSight Speakers
Other: CEO/CSO PhytoTEK LLC

Dianne Davis
DiAnne Davis

MD FAAD

No financial relationships to disclose.

Hadar Lev-Tov

MD MAS

Ownership Interest / Stock Holder: LearnSkin

Iltefat Hamzavi, MD
Iltefat Hamzavi

MD

Grant from Estee Lauder
Investigator Clinuvel
Investigator Incyte, Pfizer, Avita, ITN,Ferndale Labs
Consultant Pfizer, Abbvie, Novartis, Aclaris

Jason Ezra Hawkes

MD MS FAAD

Consulting Fees: AbbVie, Arcutis, LEO, Lilly, Novartis, Sanofi, UCB, VisualDx
Ownership Interest / Stock Holder: Regeneron Pharmaceuticals (Spouse)
Royalty: UpToDate
Honorarium: National Psoriasis Foundation
Employee: Regeneron Pharmaceuticals (Spouse)

Jessica Maloh

ND

Consulting Fees: Codex Beauty (Consultant)

Joseph Alban

DAc LAc

No financial relationships to disclose.

Kathy Farah
Kathleen Farah

MD FAAFP

No financial relationships to disclose.

Keira Barr

MD

No financial relationships to disclose.

Lakshi Alderdge, MSN RN ANP-BC
Lakshi Alderdge

MSN RN ANP-BC

Consulting Fees: AbbVie, Sanofi, Regeneron, Lilly, Sun Pharma, UBC, Janssen, Bristol Myers Squibb, Dermavant, Arcutis, Incyte
Speakers Bureau: AbbVie, Sanofi, Regeneron, Lilly, Sun Pharma, UBC, Janssen, Sun Pharma

Lawrence Eichenfield

MD

Consultant or investigator, or on a data safety monitoring board for: Abbvie, Almirall, Asana, Cutanea, Dermavant, Dermira, Forte Biosciences, Galderma Laboratories, Glenmark, Incyte, Leo Pharma, Lilly, Matrisys, Otsuka, Novartis, Otsuka, Pfizer, Regeneron, Sanofi Genzyme, Ortho Dermatology
Royalty: UptoDate, Xeroderma Pigmentosa, Elsevier, Neonatal Dermatology

Mark Cannon
Mark Cannon

DDS

Consulting Fees: Unpaid advisor to Probiora, StellaLife and Xlear

Michael Traub

ND DHANP FABNO

No financial relationships to disclose.

Neal Bhatia
Neal Bhatia

MD

Affiliations with Abbvie, Almirall, Arcutis, Arena, Biofrontera, BMS, BI, Brickell, Dermavant, EPI Health, Ferndale, Galderma, Genentech, InCyte, ISDIN, J&J, LaRoche-Posay, Leo, Lilly, Novartis, Ortho, Pfizer, P&G, Regeneron, Sanofi, Stemline, SunPharma, and Verrica

Peter Lio

MD

Grants/Research Support: Investigator – AO Biome, AbbVie, Regeneron/Sanofi GenzymeConsulting Fees: Advisory Board – Almirall, ASLAN, UCB, Dermavant, Regeneron/Sanofi Genzyme, Pfizer, LEO, AbbVie, Eli Lilly, Micreos, L’Oreal, Pierre-Fabre, Johnson & Johnson, Level Ex, Unilever, Menlo Therapeutics, Theraplex, IntraDerm, Exeltis, AOBiome, Realm Therapeutics, Altus Labs, Galderma, Verrica, Arbonne, Amyris, Bodewell, Burt’s Bees, My-Or Diagnostics, and Kimberly-Clark
Speakers Bureau: Speaker – Pfizer, Regeneron/Sanofi Genzyme, Galderma, Lilly, LEOOwnership Interest / Stock Holder: Stock options: Micreos, Altus Labs Royalty: Patent holder/Royalties – Theraplex AIM OTC moisturizer
Other: Board Member – National Eczema Association

Pushpa Soundararajan, RD MBA RDN LDN AP CYI
Pushpa Soundararajan

RD MBA RDN LDN AP CYI

No financial relationships to disclose.

Raja Sivamani, MD MS AP
Raja Sivamani

MD MS AP

Grants/Research Support: Regeneron, Abbvie, Incyte, Microbiome Labs, Almond Board, Mango Board, Soy Institute, Burts BeesConsulting Fees: Regeneron, Sun Pharma, Novozymes, Abbvie, Leo Pharma, Burts BeesSpeakers Bureau: Almond BoardOwnership Interest / Stock Holder: LearnHealth – SpouseAdvisory Board: LearnHealth, Arbonne

Robert Lustig
Robert Lustig

MD

Grants/ Research Support: NIDDK (Crohn’s Disease)
Consulting Fees: Simplex Health, Kalin Health, Myka Bio, ReadOut Health
Ownership Interest / Stock Holder: BioLumen, Inc.
Royalty: Fat Chance (book), 2013

Sandra Chiu
Sandra Chiu

LAc

No financial relationships to disclose.

Sheila Farhang
Sheila Farhang

MD

No financial relationships to disclose.

Steven Daveluy

MD

Grants/Research Support: Abbvie
Consulting Fees (e.g. Advisory Board): Abbvie
Speakers Bureau: Abbvie

Steven Gurgevich
Steven Gurgevich

PhD

Ownership Interest / Stock Holder: President of Behavioral Medicine, Ltd.

The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this activity:

Name of Content Manager
Reported Financial Relationship
Venita Sivamani
Venita Sivamani

LearnHealth Inc. Stockholder

Your CE Source Content Manager

No financial relationships to disclose.

DISCLAIMER
The content and views presented in this educational activity are those of the speakers and do not necessarily reflect those of Your CE Source and LearnHealth Inc. The speakers have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.